EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decade-long protection of the mumps vaccine: Insights from a large-scale serological study

Zixia Qian iD, Yueling Chen, Lilian Zeng, Chumin Liang, Weizhao Lin, Can Xiong, Xinxin Li, Yingyin Deng, Liang Chen, Ying Yang, Limei Sun, Jianfeng He und 1 weitere

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Zixia Qian und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Mumps, Antibodies, Viral, Measles-Mumps-Rubella Vaccine, Mumps Vaccine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Center for Disease Control and Prevention Talents Support Program, Guangdong Science and Technology Program, Medical Scientific Research Foundation of Guangdong Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Serological surveys of mumps are important for estimating susceptibility in the population and for evaluating the effectiveness of current vaccination strategies.

Methods

A cross-sectional serological survey using an enzyme-linked immunosorbent assay was conducted on 5,147 participants in Guangdong, China, to evaluate the immunological effects of 2 doses of measles-mumps-rubella vaccine. In accordance with the instructions of the ELISA kit, the final readings represent the anti-mumps antibody titers, which are expressed in “NovaTec units”.

Results

Of the 5,147 participants, 3,888 were positive for mumps IgG antibodies, with a seroprevalence of 75.54% ( 95% CI : 74.34%-76.71%). For each age group, the mumps IgG seroprevalence rates were 74.40%, 89.02%, 85.58%, 68.60%, 69.28%, 78.42%, and 80.63% for those =60 years, respectively. In terms of the percentage decreases in anti-mumps antibody titers, in the population receiving the 1-dose vaccine, there was a mean decrease of 2.06% per year. In the population receiving 2 doses of the vaccine, the mean annual decreases were 10.33% and reached protective thresholds of approximately 12.3 years.

Conclusion

The high mumps seroprevalence in the unvaccinated population revealed neglected hidden mumps infections. A time-lapse assay of IgG antibodies indicated that the mumps vaccine provided protection for one decade, which highlights that booster vaccinations may be needed in adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MumpsAntibodies, ViralMeasles-Mumps-Rubella VaccineMumps VaccineHumansAdultAdolescentSeroepidemiologic StudiesCross-Sectional StudiesMiddle AgedYoung AdultMaleFemaleChinaChildImmunoglobulin GChild, PreschoolInfantEnzyme-Linked Immunosorbent AssayAgedMumps virus

Substanzen

Antibodies, ViralImmunoglobulin GMeasles-Mumps-Rubella VaccineMumps Vaccine

Autor:innen und Institutionen

  • School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China.
  • School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Public Health and Preventive Medicine, Jinan University, Guangzhou, Guangdong, China.
  • School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Guangdong Workstation for Emerging Infectious Disease Control and Prevention, Guangdong Provincial Key Laboratory of Pathogen Detection for Emerging Infectious Disease Response, Guangdong Provincial Center for Disease C…

ORCID-Profile: Zixia Qian, Jiufeng Sun

Förderung

  • Guangdong Provincial Center for Disease Control and Prevention Talents Support Program
  • Guangdong Science and Technology Program
  • Medical Scientific Research Foundation of Guangdong Province, China
  • Medical Scientific Research Foundation of Guangdong Province

Zitieren

APA

Qian, Z., Chen, Y., Zeng, L., Liang, C., Lin, W., Xiong, C., Li, X., Deng, Y., Chen, L., Yang, Y., Sun, L., He, J., & Sun, J. (2025). Decade-long protection of the mumps vaccine: Insights from a large-scale serological study. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013125

Vancouver

Qian Z, Chen Y, Zeng L, Liang C, Lin W, Xiong C, et al. Decade-long protection of the mumps vaccine: Insights from a large-scale serological study. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013125

BibTeX
@article{Qian2025,
  author = {Qian, Zixia and Chen, Yueling and Zeng, Lilian and Liang, Chumin and Lin, Weizhao and Xiong, Can and Li, Xinxin and Deng, Yingyin and Chen, Liang and Yang, Ying and Sun, Limei and He, Jianfeng and Sun, Jiufeng},
  title = {Decade-long protection of the mumps vaccine: Insights from a large-scale serological study},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013125}
}
Kostenlos starten →